Immuno Oncology Market
Immuno-Oncology Market Research Report By Cancer Type (Lung Cancer, Melanoma, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma), By Treatment Modality (Checkpoint Inhibitors, Adoptive Cell Therapy, Cancer Vaccines, Oncolytic Viruses, Targeted Therapies), By Biomarker Type (PD-1, PD-L1, CTLA-4, LAG-3, TIM-3, IDO), By Combination Therapies (Checkpoint Inhibitor Combinations, Checkpoint Inhibitors and Targeted Therapies, Checkpoint Inhibitors and Immunotherapy, Targeted Therapy Combinations), By Disease Stage (Early Stage, Advanced Stage, Metastatic Disease) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2034
Immuno-oncology Market Overview
As per MRFR analysis, the Immuno-Oncology Market Size was estimated at 125.69 (USD Billion) in 2024. The Immuno-Oncology Market Industry is expected to grow from 137.36 (USD Billion) in 2025 to 305.35 (USD Billion) ..